Article
Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.
PloS one - 1 Jan 2016
Yin You, Liu Yan, Pan Xiao, Chen Rui, Li Peng, Wu Hui-Juan, Zhao Zheng-Qing, Li Yan-Peng, Huang Liu-Qing, Zhuang Jian-Hua, Zhao Zhong-Xin
Abstract excerpt
Sleep alleviates Alzheimer's disease (AD)-related neuropathological processes, whereas sleep disturbance in AD patients is associated with elevated peripheral inflammatory cytokine levels. In the present study, we assessed interleukin (IL)-1β and APOEε4 polymorphisms for association with susceptibility of sleep disturbances in AD patients. A total of 123 pretreated AD patients and 120 age-, gender- and education...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
